Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 10,000 shares at $50.56 ($506K) on 2017-01-31, disclosed to the SEC on 2017-02-01.
Open-market sale of $506k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-27 | $711K | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |